| breast cancer - triple negative | ||||
| es-BC - TNBC - NA - all population | mBC - TNBC - L1 - all population | mBC-Triple negative (TNBC) - 2nd Line (L2) | mBC - TNBC - L2 - all population | |
| poly ADP-ribose polymerase (PARP) inhibitor | ||||
| olaparib | OlympiA ... | OlympiAD | ||
| talazoparib | EMBRACA | |||
| veliparib plus paclitaxel plus carboplatin | BrighTNess ... BrighTNess ... | |||
Study type:
delta: difference in rate or median (if available)
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
